The DOI matches its Crossref record; 32 of the 32 references it cites were found in a registry or an index.
Carvedilol prevents doxorubicin-induced free radical release and apoptosis in cardiomyocytes in vitro
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Prevention of Apoptosis by Bcl-2: Release of Cytochrome c from Mitochondria Blocked
Yang, J., Liu, X., Bhalla, K., Kim, C. N., Ibrado, A. M., Cai, J., Peng, T.-I., Jones, D. P., & Wang, X. (1997) · Science · doi:10.1126/science.275.5303.1129 · Cited by 4,911
Chen, Y., & Wu, H. (2010) · Chinese Science Bulletin · doi:10.1007/s11434-010-3275-4 · Cited by 1,594
Royall, J. A., & Ischiropoulos, H. (1993) · Archives of Biochemistry and Biophysics · doi:10.1006/abbi.1993.1222 · Cited by 1,119
Superoxide production in rat hippocampal neurons: selective imaging with hydroethidine
Bindokas, V., Jordan, J., Lee, C., & Miller, R. (1996) · The Journal of Neuroscience · doi:10.1523/jneurosci.16-04-01324.1996 · Cited by 859
Antonsson, B., & Martinou, J.-C. (2000) · Experimental Cell Research · doi:10.1006/excr.2000.4839 · Cited by 792
Anthracycline cardiomyopathy monitored by morphologic changes.
Billingham, M. E., Mason, J. W., Bristow, M. R., & Daniels, J. R. (1978) · PubMed · Cited by 586
Childs, A. C., Phaneuf, S., Dirks, A. J., Phillips, T., & Leeuwenburgh, C. (2002) · PubMed · Cited by 525
Critical evaluation of the use of hydroethidine as a measure of superoxide anion radical
Benov, L., Sztejnberg, L., & Fridovich, I. (1998) · Free Radical Biology and Medicine · doi:10.1016/s0891-5849(98)00163-4 · Cited by 496
Kotamraju, S., Konorev, E. A., Joseph, J., & Kalyanaraman, B. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m003890200 · Cited by 372
Regulation of Cardiomyocyte Apoptotic Signaling by Insulin-like Growth Factor I
Wang, L., Ma, W., Markovich, R., Chen, J.-W., & Wang, P. H. (1998) · Circulation Research · doi:10.1161/01.res.83.5.516 · Cited by 287
Mitochondrial dysfunction is an early indicator of doxorubicin-induced apoptosis
Green, P. S., & Leeuwenburgh, C. (2002) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/s0925-4439(02)00144-8 · Cited by 252
Yue, T.-L., Ma, X.-L., Wang, X., Romanic, A. M., Liu, G.-L., Louden, C., Gu, J.-L., Kumar, S., Poste, G., Ruffolo, R. R., et al. (1998) · Circulation Research · doi:10.1161/01.res.82.2.166 · Cited by 234
Molecular Basis of Anthracycline-Induced Cardiotoxicity and Its Prevention
Horenstein, M. S., Vander Heide, R. S., & L'Ecuyer, T. J. (2000) · Molecular Genetics and Metabolism · doi:10.1006/mgme.2000.3043 · Cited by 228
Bax, Bid and the permeabilization of the mitochondrial outer membrane in apoptosis
Crompton, M. (2000) · Current Opinion in Cell Biology · doi:10.1016/s0955-0674(00)00110-1 · Cited by 223
β-Adrenergic Receptor Subtypes Differentially Affect Apoptosis in Adult Rat Ventricular Myocytes
Zaugg, M., Xu, W., Lucchinetti, E., Shafiq, S. A., Jamali, N. Z., & Siddiqui, M. A. Q. (2000) · Circulation · doi:10.1161/01.cir.102.3.344 · Cited by 212
Daunorubicin-Induced Apoptosis in Rat Cardiac Myocytes Is Inhibited by Dexrazoxane
Sawyer, D. B., Fukazawa, R., Arstall, M. A., & Kelly, R. A. (1999) · Circulation Research · doi:10.1161/01.res.84.3.257 · Cited by 207
Adriamycin-induced Cardiomyocyte and Endothelial Cell Apoptosis: In Vitro and In Vivo Studies
Wu, S. (2002) · Journal of Molecular and Cellular Cardiology · doi:10.1006/jmcc.2002.2110 · Cited by 197
Iwai-Kanai, E., Hasegawa, K., Araki, M., Kakita, T., Morimoto, T., & Sasayama, S. (1999) · Circulation · doi:10.1161/01.cir.100.3.305 · Cited by 192
Vleet, J. F. V., Ferrans, V. J., & Weirich, W. E. (1980) · PubMed · Cited by 169
Venturini, M., Michelotti, A., Del Mastro, L., Gallo, L., Carnino, F., Garrone, O., Tibaldi, C., Molea, N., Bellina, R. C., Pronzato, P., et al. (1996) · Journal of Clinical Oncology · doi:10.1200/jco.1996.14.12.3112 · Cited by 165
Apoptosis in Adriamycin Cardiomyopathy and Its Modulation by Probucol
Kumar, D., Kirshenbaum, L. A., Li, T., Danelisen, I., & Singal, P. K. (2001) · Antioxidants & Redox Signaling · doi:10.1089/152308601750100641 · Cited by 159
Melatonin as an effective protector against doxorubicin-induced cardiotoxicity
Liu, X., Chen, Z., Chua, C. C., Ma, Y.-S., Youngberg, G. A., Hamdy, R., & Chua, B. H. L. (2002) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.01023.2001 · Cited by 159
Flow cytometric detection of hydrogen peroxide production induced by doxorubicin in cancer cells
Ubezio, P., & Civoli, F. (1994) · Free Radical Biology and Medicine · doi:10.1016/0891-5849(94)90129-5 · Cited by 150
FEUERSTEIN, G. Z., & Ruffolo, R. R., Jr. (1995) · European Heart Journal · doi:10.1093/eurheartj/16.suppl_f.38 · Cited by 147
Mitani, I., Jain, D., Joska, T. M., Burtness, B. A., & Zaret, B. L. (2003) · Journal of Nuclear Cardiology · doi:10.1067/mnc.2003.7 · Cited by 140
Cytoprotective agents for anthracyclines.
Rt, D. (1996) · PubMed · Cited by 119
Protective effects of carvedilol against doxorubicin-induced cardiomyopathy in rats
Matsui, H., Morishima, I., Numaguchi, Y., Toki, Y., Okumura, K., & Hayakawa, T. (1999) · Life Sciences · doi:10.1016/s0024-3205(99)00362-8 · Cited by 103
Apoptosis in Isolated Adult Cardiomyocytes Exposed to Adriamycina
Kumar, D., Kirshenbaum, L. A., Li, T., Danelisen, I., & Singal, P. K. (1999) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1999.tb09233.x · Cited by 91
Antioxidant action of the antihypertensive drug, carvedilol, against lipid peroxidation
Noguchi, N., Nishino, K., & Niki, E. (2000) · Biochemical Pharmacology · doi:10.1016/s0006-2952(99)00417-7 · Cited by 89
Amlodipine inhibits doxorubicin-induced apoptosis in neonatal rat cardiac myocytes
Yamanaka, S., Tatsumi, T., Shiraishi, J., Mano, A., Keira, N., Matoba, S., Asayama, J., Fushiki, S., Fliss, H., & Nakagawa, M. (2003) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(02)02935-2 · Cited by 76
McPhillips, J. J., Schwemer, G. T., Scott, D. I., Zinny, M. A., & Patterson, D. (1988) · Drugs · doi:10.2165/00003495-198800366-00015 · Cited by 51
Yuan, L., Inoue, S., Saito, Y., et al. (1993) · Experimental Cell Research · doi:10.1006/excr.1993.1323 · Cited by 42
Cited by
Anthracycline Cardiotoxicity: Prevalence, Pathogenesis and Treatment
Volkova, M., & Russell, R. (2012) · Current Cardiology Reviews · doi:10.2174/157340311799960645 · Cited by 872
Protective Effects of Carvedilol Against Anthracycline-Induced Cardiomyopathy
Kalay, N., Basar, E., Ozdogru, I., Er, O., Cetinkaya, Y., Dogan, A., Oguzhan, A., Eryol, N. K., Topsakal, R., Ergin, A., et al. (2006) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2006.07.052 · Cited by 713
Bosch, X., Rovira, M., Sitges, M., Domènech, A., Ortiz-Pérez, J. T., de Caralt, T. M., Morales-Ruiz, M., Perea, R. J., Monzó, M., & Esteve, J. (2013) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2013.02.072 · Cited by 632
Doxorubicin‐Induced Cardiotoxicity: From Bioenergetic Failure and Cell Death to Cardiomyopathy
Carvalho, F. S., Burgeiro, A., Garcia, R., Moreno, A. J., Carvalho, R. A., & Oliveira, P. J. (2014) · Medicinal Research Reviews · doi:10.1002/med.21280 · Cited by 569
Oxidative stress injury in doxorubicin-induced cardiotoxicity
Songbo, M., Lang, H., Xinyong, C., Bin, X., Ping, Z., & Liang, S. (2019) · Toxicology Letters · doi:10.1016/j.toxlet.2019.02.013 · Cited by 566
Metadata
- Authors
- Spallarossa, P., Garibaldi, S., Altieri, P., Fabbi, P., Manca, V., Nasti, S., Rossettin, P., Ghigliotti, G., Ballestrero, A., & Patrone, F.
- Venue
- Journal of Molecular and Cellular Cardiology
- Publisher
- Elsevier BV
- Published
- 2004-10
- Volume
- 37
- Issue
- 4
- Pages
- 837-846
- ISSN
- 0022-2828 (ISSN-L)
- OpenAlex
- W1980502996
- Cited by
- 294
- References
- 32
- FWCI
- 6.82
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.